These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4108891)

  • 1. The antimycobacterial activity of capreomycin.
    Lucchesi M
    Antibiot Chemother; 1970; 16():27-31. PubMed ID: 4108891
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of kanamycin, viomycin and capreomycin resistance of Mycobacterium tuberculosis].
    Tomoda T; Minami Y; Maekawa Y; Oi Y
    Rinsho Byori; 1971 Jun; 19(6):423-6. PubMed ID: 4111341
    [No Abstract]   [Full Text] [Related]  

  • 3. Resistance system of Mycobacterium bovis B.C.B. to aminoglycoside- and peptide-antibiotics. Comparison of resistant phenotypes between Mycobacterium tuberculosis and Mycobacterium bovis.
    Tsukamura M
    Microbiol Immunol; 1980; 24(1):11-9. PubMed ID: 6153747
    [No Abstract]   [Full Text] [Related]  

  • 4. Some experimental aspects of cross-resistance between capreomycin and viomycin.
    Algeorge G; Petre A
    Antibiot Chemother; 1970; 16():32-5. PubMed ID: 4108892
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of streptomycin-resistance of Mycobacterium tuberculosis on induction rate of resistance to kanamycin, viomycin and capreomycin and on cross-resistance among these drugs].
    Nagata A; Mase M; Yamamoto M; Nakamura H
    Kekkaku; 1969 Jun; 44(6):173-9. PubMed ID: 4308767
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anti-bacterial activity of capreomycin, kanamycin, or viomycin against drug-resistant tubercle bacilli isolated from patients].
    Endo K
    Jpn J Antibiot; 1971 Jun; 24(3):149-51. PubMed ID: 4327336
    [No Abstract]   [Full Text] [Related]  

  • 7. Cross-resistance in M. tuberculosis to kanamycin, capreomycin and viomycin.
    McClatchy JK; Kanes W; Davidson PT; Moulding TS
    Tubercle; 1977 Mar; 58(1):29-34. PubMed ID: 68613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The susceptibility of mycobacteria to rifamide and rifampicin.
    Clark J; Wallace A
    Tubercle; 1967 Jun; 48(2):144-8. PubMed ID: 4293697
    [No Abstract]   [Full Text] [Related]  

  • 9. [In vitro antituberculous activity of lividomycin].
    Kobayashi F; Nagoya T; Eda J; Yoshimura Y
    Jpn J Antibiot; 1972 Dec; 25(6):360-6. PubMed ID: 4125073
    [No Abstract]   [Full Text] [Related]  

  • 10. Study on tuberactinomycin-N. I. In vitro Antibacterial activity of TUM-N on Tubercle bacilli isolated from patients.
    Shimizu T
    Jpn J Antibiot; 1974 Aug; 27(4):463-70. PubMed ID: 4140247
    [No Abstract]   [Full Text] [Related]  

  • 11. Cross-resistance relationships between capreomycin, kanamycin, and viomycin resistances in tubecle bacilli from paients.
    Tsukamura M
    Am Rev Respir Dis; 1969 May; 99(5):780-2. PubMed ID: 4306213
    [No Abstract]   [Full Text] [Related]  

  • 12. Investigation into the relationship of M ulcerans to M. buruli and other mycobacteria.
    Schröder KH
    Am Rev Respir Dis; 1975 Apr; 111(4):559-62. PubMed ID: 47730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The degree of cross-resistance to kanamycin (KM) of tubercle bacilli resistant to capreomycin (CPM), and the degree of cross-resistance to KM and CPM of tubercle bacilli resistant to viomycin (VM) (author's transl)].
    Inagake H; Yamadori H; Inoue N; Mabuchi H; Ikeda N; Maekawa N
    Kekkaku; 1980 Jul; 55(7):323-30. PubMed ID: 6162994
    [No Abstract]   [Full Text] [Related]  

  • 14. Some correlations between chemical structure and mode of action of tuberculostatica. Researches on capreomycin and isoxyl.
    Păunescu E; Stoinescu M; Zaharescu C; Drăguşanu E
    Antibiot Chemother; 1970; 16():10-6. PubMed ID: 4108883
    [No Abstract]   [Full Text] [Related]  

  • 15. [Critical concentrations for resistances of tubercle bacilli to tuberactinomycin-N, viomycin, capreomycin, and lividomycin in patients treated with these agents (cross-resistance-relationships among resistances to aminoglucoside-antibiotics found during chemotherapy for tuberculosis) (author's transl)].
    Tsukamura M; Mizuno S; Murata H; Oshima T
    Kekkaku; 1975 May; 50(4-5):123-30. PubMed ID: 49449
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cross resistance of tubercle bacilli to KM, VM, CPM, LVM and TUM. I. The sensitivity of human tubercle bacilli isolated from patients to the five antibiotics (author's transl)].
    Saito T; Fukuhara Y
    Kekkaku; 1974 Mar; 49(3):57-61. PubMed ID: 4136031
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antitubercular effect of capreomycin in vitro].
    Janowiec M
    Gruzlica; 1969 Jul; 37(7):629-35. PubMed ID: 4981783
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cross resistance of tubercle bacilli to KM, VM, CPM, LVM, and TUM. II. The susceptibility of antibiotic-resistant strains which were obtained in vitro to the five antibiotics (author's transl)].
    Saito T; Fukuhara Y
    Kekkaku; 1974 Apr; 49(4):91-6. PubMed ID: 4137393
    [No Abstract]   [Full Text] [Related]  

  • 19. [Activities of rifampicin, capreomycin, viomycin or kanamycin against Mycobacterium tuberculosis isolated from tuberculosis patients].
    Endo K
    Jpn J Antibiot; 1970 Aug; 23(4):387-9. PubMed ID: 4321638
    [No Abstract]   [Full Text] [Related]  

  • 20. Cross-resistant relationships among the aminoglucoside antibiotics in Mycobacterium tuberculosis.
    Tsukamura M; Mizuno S
    J Gen Microbiol; 1975 Jun; 88(2):269-74. PubMed ID: 50402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.